JPRN-UMIN000035933尚未招募未知
Androgen-deprivation therapy plus abiraterone and prednisolone vs combined androgen blockade for high-risk, metastatic, castration-sensitive prostate cancer : A randomized controlled trial - Androgen-deprivation therapy plus abiraterone and prednisolone vs combined androgen blockade for high-risk, metastatic, castration-sensitive prostate cancer : A randomized controlled trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1. Cases with no prostate biopsy 2. Cases with other cancers
研究者
相似试验
已完成
不适用
Deferred combined androgen blockade therapy using antiandrogen in metastatic prostate cancer patients treated with GnRH antagonist, degarelixMetastatic prostate cancer (Untreated)JPRN-UMIN000013668Department of Urooncology, Saitama Medical University International Medical Center70
招募中
不适用
Deferred combined androgen blockade therapy using antiandrogen in hormone-refractory metastatic prostate cancer patients treated with Degarelix, GnRH antagonistBone metastatic prostate cancerJPRN-UMIN000011437Osaka University Graduate School of Medicine, Department of Organ Specific Regulation (Urology)200
尚未招募
不适用
Role of addition Abiraterone to Androgen Deprivation Therapy (ADT) in Metastatic Hormone Sensitive Carcinoma Prostate in Indian meCTRI/2020/07/026545AIIMS Bhubaneswar
进行中（未招募）
4 期
The effect of intermittent versus continuous androgen deprivation therapy in Chinese patients with advanced prostate cancer: A prospective controlled Trial from ChinaCancer - Prostateprostate cancerACTRN12613000107729Changhai Hospital, Second Military Medical University100
进行中（未招募）
1 期
Comparison of targeted radiotherapy with and without short-term hormonal treatment (6 months)CTIS2024-511252-41-00niversitair Medisch Centrum Groningen280